Table 4

List of patients with variants in candidate disease genes

ProbandGeneVariant: genomic coordinatesNM numbercDNAProteinFunctional impact predictionGene FunctionKO/KD phenotype*Expression in Human Neocortex†References
SIFTPolyPhen2MutAsse.CondelPmutMutTast
2HTTchr4:3133374
chr4:3162034
NM_002111c.C2108T
c.C3779T
p.(P703L)
p.(T1260M)
NP
NP
P
P
P
NP
P
NP
NP
NP
P
P
Ubiquitously expressed nuclear protein that regulates transcription; involved in vesicular trafficConditional mutants are small with progressive neurodegenerationModerate27, 28
4SMARCA1chrX:128599594NM_139035c.G2897Tp.(G966V)PPPPPPChromatin remodelling; Wnt signalling; Interacts with FOXG1Hemizygous male/homozygous female KO show abnormal neuron proliferation and differentiation, increased brain and heart weightModerate29, 30
9GABBR2chr9:101133817NM_005458c.G1699Ap.(A567T)PNPPNPNPPγ-aminobutyric acid (GABA) type B receptor; Regulation of neurotransmitter releaseHomozygous KO mice show clonic seizures, hyperactivity, anxiety.High31
11RHOBTB2chr8:22865220NM_001160036c.A1528Gp.(N510D)PPNPPNPNPRho GTPase family; Binds to CUL3NDHigh32
11EIF4G1chr3:184038482NM_182917c.G602Ap.(R201H)PPNPPNPPRecruitment of mRNA to the 40S ribosomal subunitNDHigh33
  • *The Jackson laboratory, 2014.

  • Allen Institute for Brain Science, 2004.

  • KO, knockout; KD, knockdown; ND, not described.